Today: 13 March 2026
Subscribe

Marcin Frąckiewicz

CEO of TS2 Space and founder of TS2.tech. Expert in satellites, telecommunications, and emerging technologies, covering trends in space, AI, and connectivity.

Metsera Stock Skyrockets as Pfizer-Novo Clash in $9B Bidding War

Metsera Stock Skyrockets as Pfizer-Novo Clash in $9B Bidding War

Novo Nordisk launched a hostile bid for Metsera on Oct. 30, 2025, offering up to $9 billion and topping Pfizer’s earlier $7.3 billion deal. Metsera shares jumped about 19% in premarket trading. The board called Novo’s offer “superior,” giving Pfizer four days to respond. A law firm began investigating whether the original Pfizer deal was fair to shareholders.
30 October 2025
····
Biogen Stock Slides on Q3 Beat as Guidance Cut Shocks Investors

Biogen Stock Slides on Q3 Beat as Guidance Cut Shocks Investors

Biogen shares fell about 2.6% after hours Oct. 30 following Q3 results that beat estimates, with revenue at $2.53 billion and adjusted EPS of $4.81. The company cut 2025 non-GAAP EPS guidance to $14.50–$15.00, citing a $1.25 per-share R&D charge. Leqembi sales reached $121 million, up 80% year-over-year. Biogen licensed Vanqua Bio’s inflammation drug for up to $1.06 billion.
30 October 2025
··
GLE Stock Skyrockets 50%: Key Facts & What’s Next

GLE Stock Skyrockets 50%: Key Facts & What’s Next

Global Engine Group (Nasdaq: GLE) closed at $0.6526 on Oct. 29, then surged to nearly $1.00 in early Oct. 30 trading, a gain of about 50%. No news or filings explained the spike. GLE, a small Hong Kong tech firm, reported a sharp drop in revenue and a net loss for its latest fiscal year. The stock remains down 62% for 2025.
30 October 2025
·
Cigna (CI) Rallies on Q3 Beat & Rebate-Free Drug Plan – Is a 25% Upside in Sight?

Cigna (CI) Rallies on Q3 Beat & Rebate-Free Drug Plan – Is a 25% Upside in Sight?

Cigna shares closed at $299.12 on Oct 29, down 3% for the week, before rising to $303 in Oct 30 premarket trading. The company reported Q3 revenue of $69.7 billion and net income of $1.87 billion, beating forecasts and reaffirming its full-year outlook. Cigna launched a new pharmacy benefit model and Evernorth invested $3.5 billion in Shields Health. Analyst consensus remains bullish with a $370–$377 price target.
30 October 2025
···
Hot GDP Surprise Shatters Wall Street’s Rally – Stocks Slide on Fed Jitters (Sept 25, 2025)

Stock Market Rollercoaster: Tech Stocks Tumble After Trump-Xi Trade Truce & Fed’s Hawkish Signals

Trump and Xi agreed to cut some tariffs and resume Chinese soybean purchases, with China pausing rare-earths export curbs for a year. The U.S. Fed trimmed rates by 25 basis points but signaled caution on further cuts, boosting Treasury yields and the dollar. Mega-cap tech stocks slid after Meta’s earnings miss, while Alphabet and Nvidia surged. The Nasdaq hit a record high, but global equities were mixed amid rate and trade uncertainty.
30 October 2025
·······
Novo Nordisk (NVO) Stock Tanks as Weight-Loss Empire Faces Boardroom Coup and Fierce Rivalry

Novo Nordisk hijacks Pfizer’s Metsera deal with a $9B bid – obesity-drug war heats up

Novo Nordisk launched an $8.5 billion unsolicited bid for obesity drugmaker Metsera, topping Pfizer’s $7.3 billion agreed deal. Novo’s offer values Metsera at $56.50 per share in cash plus up to $21.25 in milestone payments. Metsera shares jumped 18% premarket, while Novo’s stock fell 3%. Pfizer called Novo’s bid “reckless” and warned it could harm competition.
30 October 2025
····
Merck (MRK) Stock Could Skyrocket: Key Drug Approvals & Analyst Targets Unveiled

Merck (MRK) Stock Dips on Earnings Beat — Will Pipeline Boost Spur a Rally?

Merck shares fell about 2% after hours Oct. 30 despite Q3 revenue of $17.28 billion and $2.58 adjusted EPS, both above estimates. Keytruda sales rose 10% to $8.1 billion. The company narrowed its 2025 sales outlook and raised profit guidance. Recent milestones include FDA approval of subcutaneous Keytruda and the $10 billion acquisition of Verona Pharma.
30 October 2025
···
Cambium Networks (CMBM) Stock Soars 377% on Starlink Tie-Up — Delisting Threats Loom

Cambium Networks (CMBM) Stock Soars 377% on Starlink Tie-Up — Delisting Threats Loom

Cambium Networks shares soared 377% to $2.95 on Oct 29 after announcing integration of its ONE Network platform with SpaceX’s Starlink. After-hours trading pushed the stock as high as $6.69. The rally followed recent Nasdaq delisting warnings and a CFO departure. Cambium’s market cap reached about $83 million, with analysts split on the outlook amid ongoing losses and volatile trading.
30 October 2025
··
VCI Global Stock Skyrockets 88% on AI-Crypto Token News: Microcap VCIG Rallies Afterhours

VCI Global Stock Skyrockets 88% on AI-Crypto Token News: Microcap VCIG Rallies Afterhours

VCIG shares jumped 87.8% in after-hours trading Oct. 29 to $3.38 after announcing its Smart Bridge unit will exclusively manage 1 billion XVIQ AI/GPU crypto tokens. The stock quickly fell back to around $1.80 by midday Oct. 30. VCIG recently guided for 2025 revenue of $47.3 million, up 70% year-over-year, and plans to launch a gold-backed crypto platform by Q2 2026. Market cap remains about $2–3 million.
30 October 2025
····
Inside Samsung: How the Tech Giant is Dominating Every Industry It Touches

Samsung Stock Soars on AI Chip Boom – Q3 Earnings Crush Estimates

Samsung Electronics shares jumped 3.6% to ₩104,100 on October 30, hitting a 52-week high after Q3 revenue reached ₩86.1 trillion and operating profit rose 32% to ₩12.2 trillion, fueled by record AI chip sales. The company plans major expansion of high-bandwidth memory production for AI servers. Samsung also launched its first Galaxy XR headset and announced a DRAM supply deal with OpenAI.
30 October 2025
····
Bubble or Boom? Magnificent Seven Stocks Face Critical Earnings Showdown

Alphabet (GOOG) Hits Record High on Q3 Earnings Beat, AI Boom Fueling Rally

Alphabet shares jumped 6% to a record high near $270 on Oct. 30 after third-quarter earnings and revenue beat forecasts. Google’s ad revenue rose 12.6% to $74.2 billion, and cloud sales surged 34% to $15.16 billion. The company raised 2025 capital spending to as much as $93 billion for AI and cloud expansion. Wall Street remains bullish, with most analysts rating the stock a “Buy.”
30 October 2025
····
Chipotle Stock Tumbles on Third Forecast Cut — Can the Burrito Chain Bounce Back?

Chipotle Stock Craters After Tepid Q3 Earnings – What’s Next for CMG?

Chipotle shares plunged 18% pre-market Oct. 30 after management cut its 2025 same-store sales forecast to a low-single-digit decline, citing persistent macroeconomic pressures. Q3 revenue rose 7.5% to $3.0 billion, but same-store sales grew just 0.3% as customer traffic fell for the third straight quarter. Chipotle opened 84 new restaurants and repurchased $686.5 million in stock. The stock is down 34% year-to-date.
30 October 2025
···
Fiserv Earnings Miss Expectations, Shares Slide – What’s Next for the Fintech Giant?

Shock Selloff: Fiserv (FI) Stock Plunges 40% After ‘Shockingly Bad’ Q3, Major Shakeup Unveiled

Fiserv shares plunged about 42% to a 52-week low near $66 on Oct. 29, 2025, after missing Q3 estimates and slashing 2025 guidance. Adjusted EPS came in at $2.04 on $4.92 billion revenue, both well below forecasts. CEO Mike Lyons announced a turnaround plan and major leadership changes. The company will move its listing from NYSE to Nasdaq on Nov. 11.
30 October 2025
··
Microsoft Stock Soars on AI and Cloud Frenzy – Analysts Eye $600+ Price Targets

Microsoft Stock Nears All-Time High on AI, Cloud Boom – Is $625 Next?

Microsoft shares traded near $541 on Oct. 30, close to a 52-week high, with a market cap over $4 trillion after strong Q1 FY2026 results. Revenue rose 18% to $77.7 billion, driven by 40% Azure growth; EPS beat forecasts. Microsoft signed a $17.4 billion GPU cloud deal and joined a $40 billion data center consortium to expand AI capacity. Analysts set 12-month price targets near $620–650.
30 October 2025
··········
MP Materials Stock Soars on Pentagon and Apple Breakthroughs – 400% YTD Rally Explained

MP Materials Stock Surges on Rare-Earth Export Truce – Analysts Weigh In

MP Materials closed at $64.29 on Oct. 29, down from a mid-October peak of $100.25 after U.S.–China trade news triggered a sharp pullback. Shares remain up nearly 300–380% year-to-date, fueled by a $400 million U.S. Defense Department investment and a $500 million Apple supply deal. MP remains unprofitable, posting a Q2 loss of $0.13 per share despite 84% revenue growth. Analyst consensus targets average $77.80.
30 October 2025
·
Dow Dips as Fed Fears Slam Tech Stocks – Hot Economic Data Rattles Wall Street (Sept 25, 2025)

Powell’s Hawkish U-Turn and Trump–Xi ‘Mini-Deal’ Leave S&P 500 Futures on Edge

The Fed cut rates by 25 basis points to 3.75–4.00% on Oct 29, but Chair Powell warned a December cut is “not a foregone conclusion.” Nasdaq closed at a record 23,958, while S&P 500 was flat and Dow slipped. Trump announced a one-year “mini-deal” with China, easing some tariffs. Big Tech earnings were mixed: Nvidia rose, Microsoft and Meta fell, Alphabet surged.
30 October 2025
·······
Big Pharma’s Billion-Dollar Bet: Inside Eli Lilly’s $5B Virginia Factory and America’s New Drug Manufacturing Boom

Eli Lilly Stock on Fire: GLP-1 Bonanza, Big Earnings & AI Pivot Drive Rally

Eli Lilly reported Q3 2025 revenue of $17.60 billion, up 54% year-over-year, and raised full-year EPS guidance to $23.00–23.70. Shares closed at $813.53 on Oct. 29, down 2% over the week after hitting highs above $850 earlier in the month. The FDA approved Inluriyo for metastatic breast cancer, and the EU cleared Kisunla for early Alzheimer’s. Wall Street’s average 12-month price target stands near $939.
30 October 2025
···
Meta’s Q3 Showdown: Can AI Spend and Ad Growth Drive Another Rally?

Meta Stock Skyrockets on AI Push – Will It Keep Soaring?

Meta shares closed at $752 on Oct. 29, near record highs, before dipping up to 9% after mixed Q3 results and then rebounding. Q3 revenue rose 26% to $51.24 billion, but a $15.9 billion tax charge cut GAAP EPS to $1.05. Meta announced a $27 billion AI data center project in Louisiana and plans to buy AI-chip startup Rivos for $2 billion. The company also launched Ray-Ban Meta “Display” glasses, which quickly sold out.
30 October 2025
··
1 … 197 198 199 200 201 … 358

Stock Market Today

  • 4 Singapore Blue-Chip Stocks Reporting Higher Profits and Dividends
    March 12, 2026, 11:46 PM EDT. Four Singapore blue-chip stocks-DBS Group, Keppel Ltd., and two others-have recently posted increased profits and announced higher dividend payouts, signaling strong business fundamentals amid market volatility. DBS reported a 3% profit decline to S$11 billion in FY2025 due to higher taxes but saw a 3% rise in total income and an 18% surge in fee income, supporting a 5.5% dividend yield including a special payout. Keppel Ltd. achieved a 39% jump in core net profit to S$1.1 billion, driving a 38% dividend increase to S$0.47 per share and delivering a 3.8% yield. These profit and dividend increases reflect managements' confidence and demonstrate how disciplined transformation and steady earnings growth underpin sustainable shareholder returns in Singapore's blue-chip sector.
Go toTop